These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23277264)

  • 1. Effect of topiramate on weight gain in patients receiving atypical antipsychotic agents.
    Mahmood S; Booker I; Huang J; Coleman CI
    J Clin Psychopharmacol; 2013 Feb; 33(1):90-4. PubMed ID: 23277264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
    Ellinger LK; Ipema HJ; Stachnik JM
    Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials.
    Kramer CK; Leitão CB; Pinto LC; Canani LH; Azevedo MJ; Gross JL
    Obes Rev; 2011 May; 12(5):e338-47. PubMed ID: 21438989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
    Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate's effectiveness on weight reduction in overweight/obese persons with schizophrenia: study protocol for a randomized controlled trial.
    Chandradasa M; Champika L; de Silva S; Kuruppuarachchi KALA
    Trials; 2017 Sep; 18(1):435. PubMed ID: 28931411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of add-on topiramate therapy in psychiatric patients with weight gain.
    Cates ME; Feldman JM; Boggs AA; Woolley TW; Whaley NP
    Ann Pharmacother; 2008 Apr; 42(4):505-10. PubMed ID: 18364406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate.
    Lin YH; Liu CY; Hsiao MC
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):613-5. PubMed ID: 16194268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of Topiramate for atypical antipsychotic-induced body weight gain and metabolic adversities: a systematic review and meta-analysis].
    Liang H; Li H; Hu Y; Li S; Lü L; Song X
    Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(3):216-23. PubMed ID: 26879726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term topiramate treatment of psychotropic drug-induced weight gain: a retrospective chart review.
    Khazaal Y; Chatton A; Rusca M; Preisig M; Zullino D
    Gen Hosp Psychiatry; 2007; 29(5):446-9. PubMed ID: 17888813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate for reversing atypical antipsychotic weight gain.
    Lessig MC; Shapira NA; Murphy TK
    J Am Acad Child Adolesc Psychiatry; 2001 Dec; 40(12):1364. PubMed ID: 11765278
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with Topiramate to counteract neuroleptic induced weight gain in 10 individuals with autistic spectrum disorders.
    Canitano R
    Brain Dev; 2005 Apr; 27(3):228-32. PubMed ID: 15737706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate-induced weight loss in schizophrenia: a retrospective case series study.
    Lévy E; Agbokou C; Ferreri F; Chouinard G; Margolese HC
    Can J Clin Pharmacol; 2007; 14(2):e234-9. PubMed ID: 17565171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of topiramate on olanzapine-related weight gain in women: an 18-month follow-up observation.
    Egger C; Muehlbacher M; Schatz M; Nickel M
    J Clin Psychopharmacol; 2007 Oct; 27(5):475-8. PubMed ID: 17873679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial.
    Afshar H; Roohafza H; Mousavi G; Golchin S; Toghianifar N; Sadeghi M; Talaei M
    J Psychopharmacol; 2009 Mar; 23(2):157-62. PubMed ID: 18515465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
    Miller LJ
    Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation antipsychotic use in schizophrenia and associated weight gain: a critical review and meta-analysis of behavioral and pharmacologic treatments.
    Das C; Mendez G; Jagasia S; Labbate LA
    Ann Clin Psychiatry; 2012 Aug; 24(3):225-39. PubMed ID: 22860242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment: Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
    Hahn MK; Cohn T; Remington G
    Ann Pharmacother; 2010; 44(7-8):1349-50; author reply 1350-1. PubMed ID: 20587740
    [No Abstract]   [Full Text] [Related]  

  • 18. Is acetazolamide similar to topiramate for reversal of antipsychotic-induced weight gain?
    Schneiderhan ME; Marvin R
    Am J Ther; 2007; 14(6):581-4. PubMed ID: 18090883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis.
    Ehret M; Goethe J; Lanosa M; Coleman CI
    J Clin Psychiatry; 2010 Oct; 71(10):1286-92. PubMed ID: 20441727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of metformin for prevention of weight gain in psychiatric populations: a review.
    Newall H; Myles N; Ward PB; Samaras K; Shiers D; Curtis J
    Int Clin Psychopharmacol; 2012 Mar; 27(2):69-75. PubMed ID: 21979790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.